Adam Smith is the founder and CEO of AgentAstro, an AI-driven regulatory intelligence platform built to streamline the FDA approval process for medical devices. With a career spanning two decades at the intersection of technology, public policy, and business strategy, Adam brings a rare blend of vision, rigour, and execution to complex, high-stakes environments. His background as a technology advisor, and founder of Rise Up Strategies has shaped AgentAstro’s Mission: to radically reduce the time and cost required for medtech innovators to bring safe, effective products to market.

AgentAstro was born from Adam’s direct work with healthcare entrepreneurs, regulators, and AI developers, where he identified a critical bottleneck in FDA 510(k) submissions: the manual, fragmented, and error-prone process of predicate device analysis. Under his leadership, AgentAstro has evolved from concept to working prototype with a lean, high-performing team, supported by early partnerships with multinational device manufacturers and regulatory experts. Adam has personally led product development, funding strategy, partner negotiations, and market validation, positioning the company to deliver immediate ROI to mid- and large-cap medtech firms.

Adam continues to set AgentAstro’s long-term vision, refine its product roadmap, and steer its commercial strategy. He draws from his experience leading complex AI and data governance projects, advising Fortune 500 firms and public institutions, and building scalable digital platforms.

Beyond AgentAstro, Adam is a board-certified governance professional (ICD.D) and a certified project management professional (PMP), with a strong commitment to public interest innovation. He has advised international leaders, spearheaded economic development initiatives, and written extensively on the role of AI in regulation, ethics, and public policy